V

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

Senior Director - Multiple Teams

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • A PhD or PharmD is required.
  • At least 15 years of biotechnology or pharmaceutical industry experience, including substantial oncology drug development experience, is required.
  • Demonstrated success leading cross-functional development programs in a matrix environment is required.
  • Deep understanding of oncology clinical development, including experience across early- and late-stage development, is required.
  • Experience serving as a Medical Director, Clinical Research Physician, Program Team Leader, or comparable development leadership role is required.
  • Strong strategic thinking and the ability to integrate scientific, clinical, regulatory, operational, and commercial considerations into development plans are required.
  • Executive communication, facilitation, negotiation, and conflict-resolution skills are required.
  • Experience presenting to executive leadership teams, governance committees, boards, and external stakeholders is required.
  • A track record of advancing an oncology program through a major value inflection point, such as first-in-human entry, proof of concept, dose selection, pivotal initiation, regulatory submission, or approval, is required.
  • The ability to make decisions under uncertainty and clearly communicate rationale, assumptions, alternatives, and consequences is required.
  • The role requires high integrity, sound judgment, an enterprise mindset, and accountability for strategy and execution.
  • The ability to travel domestically and internationally as needed is required.
  • Applicants must currently be authorized to work for any employer in the United States.

Responsibilities

  • Serve as the cross-functional leader and single point of accountability for one or more oncology development programs.
  • Define and drive the overall program vision, clinical development strategy, key milestones, and integrated development plans.
  • Lead cross-functional program teams to align on objectives, priorities, timelines, resource needs, and risk mitigation strategies.
  • Partner with executive leadership and governance committees to support strategic decision-making and portfolio prioritization.
  • Ensure programs are appropriately resourced and provide oversight and input on major budget and investment decisions.
  • Use oncology and clinical development expertise to guide development strategy, clinical trial planning, data interpretation, and key program decisions.
  • Represent programs at senior leadership meetings, governance reviews, alliance meetings, regulatory interactions, and other external forums.
  • Mentor and develop team members while strengthening program leadership capabilities across the organization.
  • Own the integrated development plan and target product profile, including stage gates, evidence requirements, and clear go/no-go recommendations.
  • Chair the development team, establish decision rights and accountabilities, resolve issues promptly, and escalate material tradeoffs with a recommendation.
  • Ensure fit-for-purpose translational medicine, clinical pharmacology, biomarker, companion-diagnostic, and patient-selection strategies from first-in-human development through registration.
  • Guide indication prioritization, sequencing, combination strategy, and lifecycle planning based on scientific rationale, unmet need, speed to interpretable data, competitive intensity, regulatory feasibility, and commercial opportunity.
  • Define data-readout and evidence-generation plans that support rapid learning, early de-risking, and disciplined investment.
  • Partner with Regulatory Affairs on global strategy, health-authority engagement, dose optimization, and data-supported expedited-development opportunities.
  • Coordinate Clinical Operations, Biometrics, Safety, CMC/Technical Operations, Medical Affairs, and Commercial to ensure integrated execution, inspection readiness, and a coherent program narrative.
  • Maintain integrated financial, timeline, resource, dependency, and risk scenarios, and recommend corrective action as assumptions or data change.
  • Engage investigators, key opinion leaders, collaborators, and potential partners, incorporating external insights into program strategy.
  • Incorporate patient burden, feasibility, diversity, access, and clinically meaningful outcomes into program and study decisions.

Desired Qualifications

  • An MD and board certification in Oncology, Hematology/Oncology, or a related specialty are preferred.

About the Company

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

Vir Biotechnology uses the immune system to treat infectious diseases by engineering monoclonal antibodies and exploring T cell vaccines, powered by an AI-assisted antibody discovery platform. Its therapies target diseases with high global impact, including hepatitis B, hepatitis delta, HIV, influenza, COVID-19, RSV/hMPMV, and HPV, with an investigational HIV T cell vaccine in development. Monoclonal antibodies specifically target viral proteins to block infection or mark pathogens for immune attack, while AI helps design and optimize these antibodies. The company differentiates itself through its combination of a proprietary mAb platform, AI/ML-enabled discovery, and broad, collaborative programs to accelerate development. Its goal is to transform lives by delivering therapies that address unmet patient needs and reduce the global burden of infectious diseases.

Company size
201-500
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Vir Biotechnology

See more jobs